Golden State Medical Supply Inc. is recalling approximately 11,922 bottles of Aripiprazole (15 mg) prescription tablets, which were manufactured by Apotex Inc. and packaged by GSMS. The recall was initiated because testing showed the medication might not dissolve correctly over its remaining shelf life, potentially affecting how the drug is absorbed into the body. These tablets were distributed nationwide in 30-count bottles under the NDC number 60429-449-30. Consumers should contact their healthcare provider or pharmacist for guidance regarding their medication.
If the medication fails to dissolve according to specifications, the body may not absorb the intended amount of the drug, which could lead to a reduction in the clinical effectiveness of the treatment.
Contact healthcare provider and return to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.